STAT Plus: Liquid biopsy startup Grail files for an IPO
Liquid biopsy company Grail has filed for a $100 million initial public offering, according to SEC documents.
The company, which has raised about $2 billion from investors like Amazon founder Jeff Bezos, biopharma giant Johnson & Johnson and even a Canadian pension plan, expects to trade on NASDAQ as “GRAL.”
Continue to STAT Plus to read the full story…
Read Original Article: STAT Plus: Liquid biopsy startup Grail files for an IPO »
